Drug Profile
Research programme: breast cancer vaccine - NEMOD
Alternative Names: PankoPepLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator NEMOD Biotherapeutics [CEASED]
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 06 Apr 2006 No development reported - Preclinical for Breast cancer prevention in Germany (unspecified route)
- 23 Aug 2004 PankoPep™ is available for licensing (http://www.nemod.com)
- 15 Aug 2003 Preclinical trials in Breast cancer prevention in Germany (unspecified route)